200 related articles for article (PubMed ID: 26747281)
1. Feasibility and acceptability of injectable artesunate for the treatment of severe malaria in the Democratic Republic of Congo.
Ntuku HM; Ferrari G; Burri C; Tshefu AK; Kalemwa DM; Lengeler C
Malar J; 2016 Jan; 15():18. PubMed ID: 26747281
[TBL] [Abstract][Full Text] [Related]
2. An operational comparative study of quinine and artesunate for the treatment of severe malaria in hospitals and health centres in the Democratic Republic of Congo: the MATIAS study.
Ferrari G; Ntuku HM; Burri C; Tshefu AK; Duparc S; Hugo P; Mitembo DK; Ross A; Ngwala PL; Luwawu JN; Musafiri PN; Ngoie SE; Lengeler C
Malar J; 2015 May; 14():226. PubMed ID: 26024661
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of pre-referral rectal artesunate for severe malaria in children under 5 years by health workers and caregivers in the Democratic Republic of the Congo, Nigeria and Uganda.
Awor P; Kimera J; Athieno P; Tumukunde G; Okitawutshu J; Tshefu A; Omoluabi E; Signorell A; Brunner N; Kalenga JC; Akano B; Ayodeji K; Okon C; Yusuf O; Delvento G; Lee T; Burri C; Lengeler C; Hetzel MW
Malar J; 2022 Nov; 21(1):322. PubMed ID: 36357894
[TBL] [Abstract][Full Text] [Related]
4. Health worker and policy-maker perspectives on use of intramuscular artesunate for pre-referral and definitive treatment of severe malaria at health posts in Ethiopia.
Kefyalew T; Kebede Z; Getachew D; Mukanga D; Awano T; Tekalegne A; Batisso E; Edossa W; Mekonnen E; Tibenderana J; Baba ES; Shumba C; Nankabirwa JI; Hamade P
Malar J; 2016 Oct; 15(1):507. PubMed ID: 27756301
[TBL] [Abstract][Full Text] [Related]
5. Adherence to the referral advice after introduction of rectal artesunate for pre-referral treatment of severe malaria at the community level: a noninferiority trial in the Democratic Republic of the Congo.
Mvumbi PM; Musau J; Faye O; Situakibanza H; Okitolonda E
Malar J; 2019 Dec; 18(1):438. PubMed ID: 31864376
[TBL] [Abstract][Full Text] [Related]
6. Shifting from quinine to artesunate as first-line treatment of severe malaria in children and adults: saving more lives.
Noubiap JJ
J Infect Public Health; 2014; 7(5):407-12. PubMed ID: 24894306
[TBL] [Abstract][Full Text] [Related]
7. Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine.
Fanello C; Onyamboko M; Lee SJ; Woodrow C; Setaphan S; Chotivanich K; Buffet P; Jauréguiberry S; Rockett K; Stepniewska K; Day NPJ; White NJ; Dondorp AM
BMC Infect Dis; 2017 Aug; 17(1):575. PubMed ID: 28818049
[TBL] [Abstract][Full Text] [Related]
8. Artesunate. The standard intravenous treatment for severe attacks of malaria.
Prescrire Int; 2014 Nov; 23(154):260. PubMed ID: 25954791
[TBL] [Abstract][Full Text] [Related]
9. High adherence to malaria treatment: promising results of an adherence study in South Kivu, Democratic Republic of the Congo.
Gerstl S; Namagana A; Palacios L; Mweshi F; Aprile S; Lima A
Malar J; 2015 Oct; 14():414. PubMed ID: 26481214
[TBL] [Abstract][Full Text] [Related]
10. Artesunate versus quinine for treating severe malaria.
Sinclair D; Donegan S; Lalloo DG
Cochrane Database Syst Rev; 2011 Mar; (3):CD005967. PubMed ID: 21412892
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study.
Barnes KI; Mwenechanya J; Tembo M; McIlleron H; Folb PI; Ribeiro I; Little F; Gomes M; Molyneux ME
Lancet; 2004 May; 363(9421):1598-605. PubMed ID: 15145633
[TBL] [Abstract][Full Text] [Related]
12. Delayed anemia after treatment with injectable artesunate in the Democratic Republic of the Congo: a manageable issue.
Burri C; Ferrari G; Ntuku HM; Kitoto AT; Duparc S; Hugo P; Mitembo DK; Lengeler C
Am J Trop Med Hyg; 2014 Oct; 91(4):821-823. PubMed ID: 25071004
[TBL] [Abstract][Full Text] [Related]
13. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD; van den Broek IV; Kayembe G; Montgomery J; Pota H; Roper C
Trop Med Int Health; 2006 Oct; 11(10):1503-11. PubMed ID: 17002724
[TBL] [Abstract][Full Text] [Related]
14. Intravenous artesunate for the treatment of severe malaria.
Hess KM; Goad JA; Arguin PM
Ann Pharmacother; 2010; 44(7-8):1250-8. PubMed ID: 20551300
[TBL] [Abstract][Full Text] [Related]
15. Health worker compliance with severe malaria treatment guidelines in the context of implementing pre-referral rectal artesunate in the Democratic Republic of the Congo, Nigeria, and Uganda: An operational study.
Signorell A; Awor P; Okitawutshu J; Tshefu A; Omoluabi E; Hetzel MW; Athieno P; Kimera J; Tumukunde G; Angiro I; Kalenga JC; Akano BK; Ayodeji K; Okon C; Yusuf O; Delvento G; Lee TT; Brunner NC; Lambiris MJ; Okuma J; Cereghetti N; Buj V; Visser T; Napier HG; Lengeler C; Burri C
PLoS Med; 2023 Feb; 20(2):e1004189. PubMed ID: 36809247
[TBL] [Abstract][Full Text] [Related]
16. Severe malaria in children: A descriptive report from Kinshasa, the Democratic Republic of Congo.
Kunuanunua TS; Nsibu CN; Bodi JM; Tshibola TK; Makusi Bura M; Magoga K; Ekila MB; Situakibanza HT; Aloni MN
J Trop Pediatr; 2015 Aug; 61(4):272-8. PubMed ID: 25957436
[TBL] [Abstract][Full Text] [Related]
17. Artesunate versus quinine for treating severe malaria.
Sinclair D; Donegan S; Isba R; Lalloo DG
Cochrane Database Syst Rev; 2012 Jun; 2012(6):CD005967. PubMed ID: 22696354
[TBL] [Abstract][Full Text] [Related]
18. Intravenous artesunate for severe malaria.
Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
[TBL] [Abstract][Full Text] [Related]
19. Intravenous Artesunate Reduces Parasite Clearance Time, Duration of Intensive Care, and Hospital Treatment in Patients With Severe Malaria in Europe: The TropNet Severe Malaria Study.
Kurth F; Develoux M; Mechain M; Clerinx J; Antinori S; Gjørup IE; Gascon J; Mørch K; Nicastri E; Ramharter M; Bartoloni A; Visser L; Rolling T; Zanger P; Calleri G; Salas-Coronas J; Nielsen H; Just-Nübling G; Neumayr A; Hachfeld A; Schmid ML; Antonini P; Pongratz P; Kern P; Saraiva da Cunha J; Soriano-Arandes A; Schunk M; Suttorp N; Hatz C; Zoller T;
Clin Infect Dis; 2015 Nov; 61(9):1441-4. PubMed ID: 26187021
[TBL] [Abstract][Full Text] [Related]
20. Key factors predicting suspected severe malaria case management and health outcomes: an operational study in the Democratic Republic of the Congo.
Okitawutshu J; Signorell A; Kalenga JC; Mukomena E; Delvento G; Burri C; Mwaluke F; Buj V; Sangare M; Luketa S; Brunner N; Lee T; Hetzel M; Lengeler C; Tshefu A
Malar J; 2022 Sep; 21(1):274. PubMed ID: 36167567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
